Market Overview

Wedbush's Nierengarten on ASH Late-Breaker Related to BCMA CAR-T Therapy Showing Anti-Myeloma Activity: Says Sees Read Through to bluebird bio

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BLUE

DateFirmActionFromTo
Jun 2017Standpoint ResearchDowngradesBuyReduce
Jun 2017BMO CapitalUpgradesMarket PerformOutperform
May 2017Standpoint ResearchInitiates Coverage OnBuy

View More Analyst Ratings for BLUE
View the Latest Analyst Ratings

Posted-In: Analyst Color News Analyst Ratings

 

Related Articles (BLUE)